Will there be medical consensus that GLP-1 drugs have cardiovascular benefits beyond those provided via weight loss?
10
Ṁ170Ṁ117Aug 12
75%
chance
1H
6H
1D
1W
1M
ALL
As implied in these tweets, among other places. Closes in 3 years.
This question is managed and resolved by Manifold.
Market context
Get 
1,000 to start trading!
1,000People are also trading
Related questions
By 2029, will there be an FDA approval of GLP-1 for a substance use disorder?
51% chance
Will a majority government owned company introduce a new GLP-1 drug before 2040?
16% chance
Will GLP-1 agonists help stop or reverse the US obesity trend by end of 2027
88% chance
Will a study suggest GLP-1 agonists (and similar) have an effect on bulimia nervosa frequency or work as a treatment?
Will Donald Trump ever take a GLP-1 agonist (eg Ozempic, Mounjaro, Wegovy, Zepbound, etc) for weight loss
57% chance
[M$5k subsidy] Will any FDA-approved GLP-1 agonists be withdrawn from the market for safety reasons by...
What fraction of US adults will regularly take GLP-1 drugs in 2030?
Will a junk/fast food company use engineered additives to mitigate the effects of GLP-1 agonists (Ozempic)?
10% chance
Will a GLP-1 receptor agonist (Ozempic-like drug) be added to public water supplies in the United States by 2075?
10% chance
Clinical trial shows by 2030 that GLP-1 receptor agonists significantly reduce osteoarthritis symptoms
74% chance